🔥Telegram İfşa

Discordance in GFR Estimating Equations and Dosing Guidance by Body Mass Index and Age buff.ly/3ptvofU (FREE) Beini Lyu Lesley Inker @alexchangmd Tom Nolin @JoeCoresh Morgan Grams Tufts Medical Center Nephrology Team Hopkins Nephrology

Excited to unveil Pitt Pharmacy School’s new Bruker Avance NEO 400 MHz NMR System! An incredible resource that provides unique capabilities and research opportunities. H2P! PittResearch

Discordance in GFR Estimating Equations and Dosing Guidance by Body Mass Index and Age buff.ly/3ptvofU (FREE) Beini Lyu Lesley Inker @alexchangmd Tom Nolin @JoeCoresh Morgan Grams Tufts Medical Center Nephrology Team Hopkins Nephrology

Great work! And a wonderful example of the benefit of leveraging Pitt Health Sciences Core Research Facilities like the Small Molecule Biomarker Core mass spectrometry facility housed Pitt Pharmacy School to support research. The future is bright in the Devanathan Lab!

Always so exciting to participate in U.S. FDA workshops and to meet legends like Drs. George Schwartz, Guido Filler and Saskia de Wildt! ADEPT8 Workshop on Drug Dosing in Pediatric Patients with Renal Impairment rb.gy/9x3hik #nephropharmacology Pitt Pharmacy School

Important work underway by Dr. Renee Cloutier, PhD 📈 Pitt PERU H2P! Pitt Pharmacy School

Important work to understand the implications of using kidney function estimating equations on drug eligibility, selection, and dosing in different populations. #nephropharmacology Pitt Pharmacy School

Researchers @PittPharmacy have secured a $7.8 million grant from NIDAnews to enhance opioid use disorder treatment. pitt.ly/3SXU8YD

Long-awaited update of U.S. FDA Guidance related to Assessment of PK and Drug Dosing in people w/ Impaired Kidney Fxn now issued! Important info RE: determining kidney fxn, assessing PK of nonrenally cleared drugs, and evaluating PK and dosing during CRRT. fda.gov/regulatory-inf…

Congratulations to Dr. Morgan Butrovich on her successful PhD defense! Her work assessed 1) impact of using various kidney fxn estimation eqtns on anticancer drug selection/dosing, and 2) kinase inhibitor PK in decreased GFR. From Pitt Pharmacy School to the U.S. FDA #nephropharmacology

Congratulations to Dr. Morgan Butrovich for successfully defending her PhD dissertation! #H2P🎉    #pittpharmacy

Congrats to Pitt Pharmacy School’s Dr. Raman Venkataramanan on his well deserved Distinguished Investigator Award from Amer Coll Clin Pharm! A testament to his remarkable career achievements and legacy of excellence in research. H2P!

A study found ESKD patients’ opioid prescription rates decreased between 2011 and 2020. Mortality risk was monotonically associated with morphine milligram equivalents in patients with kidney failure who received long-term opioid prescriptions bit.ly/JASN0478 Tom Nolin

Earlier this week, members of the #PittPharmacy community gathered in Maryland — where they shared stories from their time at Pitt Pharmacy, attended the 2024 ACCP Annual Meeting, & celebrated Dr. Venkat's Distinguished Investigators Award. A proud moment for Pitt Pharmacy! #h2p

Many thanks for the invitation! @devlinpharmd Time for pharmacists to rethink the use of C-G to calculate eCrCl and instead use CKD EPI 2021 non-indexed for drug dosing? Tom Nolin Wendy St. Peter National Kidney Foundation American Society of Nephrology Pitt Pharmacy School

Great interdisciplinary team science by Manisha Jhamb and Pitt Pharmacy School's own Dr. Melanie Weltman! #nephropharmacology

Gaps in guideline-concordant care for CKD lead to poor outcomes. This study found that K-CHAMP was effective in accelerating implementation of SGLT-2i and GLP-1RA but did not increase ACEi/ARB in patients with albuminuria or moderate-high intensity statin use, or improve blood

Pain is important for patients with kidney failure, but opioid medication prescriptions are associated with morbidity and mortality. This study found that the opioid prescription rates of patients with ESKD decreased between 2011 and 2020. bit.ly/JASN0478 Tom Nolin